Almost every second person (47%) diagnosed in 2014 was a late presenter or with indication of advanced infection. This means that these individuals are only diagnosed when their immune system already starts to fail.
Most reported malaria cases in EU were travel related. Five cases were reported as locally acquired: two in France and three in Spain. The latest data on reported cases in EU is available in the 2016 Annual epidemiological report.
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
The XXVIII IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections and HIV.